Search - tctmd.com

Displaying 201 - 220 of 1134

Sort: Relevancy | Date

Presentation TCT 2024

What are the Evidence Gaps for DCBs?

Presenter: Joanna Wykrzykowska

October 30, 2024

Presentation TCT 2024

Myocardial Bridges: Cross With Caution

Presenter: Sanjog Kalra

October 30, 2024

Presentation TCT 2024

Coronary Microvascular Disease -- How Do We Move the Field Forward?

Presenter: Rasha Al-Lamee

October 30, 2024

Presentation TCT 2024

INOCA, ANOCA, MINOCA: Making Sense of Alphabet Soup

Presenter: Jennifer Tremmel

October 30, 2024

Presentation TCT 2024

Spontaneous Coronary Artery Dissection: Future Directions

Presenter: Christina Magnussen

October 30, 2024

Presentation TCT 2024

Case Presentation

Presenter: Mark Lebehn

October 30, 2024

Presentation TCT 2024

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

Presenter: Alexander Lauten

October 30, 2024

Presentation TCT 2024

Case Resolution

Presenter: Nino Mihatov

October 30, 2024

Presentation TCT 2024

Case Presentation

Presenter: Nino Mihatov

October 30, 2024

Presentation TCT 2024

Characterizing Atrial FMR: From Diagnosis to Management Pathways

Presenter: Rebecca Hahn

October 30, 2024

Presentation TCT 2024

PE is a R Heart Disease: How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

Presenter: Sanjum Sethi

October 30, 2024

Presentation TCT 2024

The Catheter Space is Getting Crowded! How Do We Sort Through All the New Devices?

Presenter: Jay Giri

October 30, 2024

Presentation TCT 2024

AI is the Future of PE Care

Presenter: Dan Shilo

October 30, 2024

Presentation TCT 2024

Case Presentation: High/High Intermediate Risk PE

Presenter: Jun Li

October 30, 2024

Presentation TCT 2024

Clinical Trial Update in 2024

Presenter: Akhilesh Sista

October 30, 2024

Presentation TCT 2024

Transcatheter Repair Versus Surgery in Atrial Mitral Regurgitation: Results From the MATTERHORN Trial

Presenter: Stephan Baldus

October 30, 2024

Presentation TCT 2024

CLASP IID Randomized Trial and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation

Presenter: Firas Zahr

October 30, 2024

Presentation TCT 2024

Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: The CLEAR IE Multicenter Registry

Presenter: Abdallah El Sabbagh

October 30, 2024

Presentation TCT 2024

The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System

Presenter: Olivier Bertrand

October 30, 2024

Presentation TCT 2024

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Presenter: Hongbo Yang

October 30, 2024

Advertisement

What are the Evidence Gaps for DCBs?

Myocardial Bridges: Cross With Caution

Coronary Microvascular Disease -- How Do We Move the Field Forward?

INOCA, ANOCA, MINOCA: Making Sense of Alphabet Soup

Spontaneous Coronary Artery Dissection: Future Directions

Case Presentation

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

Case Resolution

Case Presentation

Characterizing Atrial FMR: From Diagnosis to Management Pathways

PE is a R Heart Disease: How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

The Catheter Space is Getting Crowded! How Do We Sort Through All the New Devices?

AI is the Future of PE Care

Case Presentation: High/High Intermediate Risk PE

Clinical Trial Update in 2024

Transcatheter Repair Versus Surgery in Atrial Mitral Regurgitation: Results From the MATTERHORN Trial

CLASP IID Randomized Trial and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation

Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: The CLEAR IE Multicenter Registry

The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content